Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Benediktus, R. Goeggel, B. Jung (Biberach, Germany). In-depth characterization of in vivo LPS models. Eur Respir J 2007; 30: Suppl. 51, 313

Member's Comments

No comment yet.

Related content which might interest you: Modeling in vitro, ex vivo or in vivo? Source: Research Seminar 2013 - Optimising models for human lung diseases and drug development Year: 2013 A human-like ex vivo preclinical model for aerosol deposition studies Source: International Congress 2015 – New models for treating airway diseases Year: 2015 In vitro and in vivo studies of nanoparticles and the lung Source: International Congress 2014 – Nanomaterials and respiratory health Year: 2014 Detailed physiological profiling of patients for a study investigating the airway microbiome Source: International Congress 2018 – Innovations in equipment and their application Year: 2018 A comparative study of pulmonary host defense in murine obesity models: Important insights into neutrophil function Source: International Congress 2016 – Translational research in respiratory infections Year: 2016 Breathprinting of multiple bacterial lung pathogens in vitro and in mice: what we can learn from translational approaches Source: International Congress 2014 – Usefulness of exhaled volatile organic compounds (VOCs) for the monitoring and understanding of lung diseases Year: 2014 Imaging of animal models: in vivo we can learn more Source: Annual Congress 2008 - Computer-aided imaging of lung parenchyma and airways Year: 2008 In vivo and in vitro regulation of angiopoietin expression by bacterial lipopolysaccharides (LPS) Source: Annual Congress 2008 - Respiratory structure and function Year: 2008 Hemodynamic and respiratory assessement of an ex vivo perfused rat lung model Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues Year: 2014 In vitro and in vivo laboratory models of pleural disease Source: Eur Respir Monogr 2020; 87: 29-47 Year: 2020 Quantitative proteomic analysis: methods and applications Source: Lung Science Conference 2004 - Application of our knowledge of the basic processes of lung inflammation in lung diseases Year: 2004 In vitro and in vivo characterisation of the novel neutrophil elastase inhibitor BI 1323495 Source: Virtual Congress 2020 – Scientific advances in airway pharmacology Year: 2020 Proteomic profiling to define synergistic responses mediated by IL-17 and TNFa in the lungs Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases Year: 2018 Pulmonary mechanics in a mouse model of emphysema: in vivo and in vitro evaluation Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008 In silico model of the spectrum of reactivity to mycobacteria Source: Annual Congress 2010 - Clinical tuberculosis Year: 2010 Use of biomaterials to tissue engineer 3D models with lung organoids for in-vitro disease modelling Source: Virtual Congress 2020 – Lung epithelial development and repair in three-dimensions Year: 2020 An integrated culture system for in vitro human airway modeling Source: International Congress 2015 – Translational studies in airway cell biology Year: 2015 Proteomic and genomic profiling to identify pathogenic mechanisms of inflammation, proteolysis and wasting in a murine COPD model Source: Eur Respir J 2004; 24: Suppl. 48, 104s Year: 2004 Effects of anti-IL-5 receptor alpha in an ex vivo 3D model of COPD Source: International Congress 2019 – Advances in COPD pharmacology Year: 2019